Search

everythinglearnresearchcommunity

for

Search:↓

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

As skin cells mature, vitamin D receptor levels decrease while retinoid X receptor α levels increase.

People with the same genetic mutation for Woodhouse-Sakati syndrome can have different symptoms.

Matriptase is highly active in hair follicles and sebaceous glands, especially during hair growth phases.

EDA signaling is linked to skin disorders, various cancers, and liver disease.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

A genetic mutation in the DCAF17 gene caused Woodhouse-Sakati syndrome in a Chinese patient from a related family.

Sorafenib is effective in treating Desmoid Tumor/Deep Fibromatosis.

Estrogens generally inhibit hair growth and improve skin quality, but their exact effects on hair follicles are complex and not fully understood.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

The document concludes that Rabson-Mendenhall syndrome requires novel treatments for insulin resistance and emphasizes the importance of dental care in affected patients.

Diabetes can lead to blindness and skin problems, and managing blood sugar and blood pressure is crucial to prevent these complications.

The document explains the genetic causes and characteristics of inherited hair disorders.

A woman with childhood growth hormone deficiency had multiple hormone deficiencies and developed serious lung and kidney problems later in life.

Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.

Oral contraceptives provide various health benefits beyond birth control, including managing menstrual issues, skin conditions, pain, and reducing the risk of certain cancers.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

Finasteride use is not clearly linked to an increased risk of male breast cancer.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

The patient with severe hirsutism improved after being diagnosed with non-classic congenital adrenal hyperplasia and treated with corticosteroids.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

No definitive link between finasteride and male breast cancer, but further research is needed.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Finasteride may cause breast enlargement, low testosterone a risk factor.